drugset / Trial / NCT01543139

Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression

NCT01543139

Phase 2 Withdrawn Ewha Womans University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This proposed research is aimed to investigate the efficacy and safety of combined cytidine- and creatine-containing drug and dietary supplement in treating bipolar depression and to evaluate changes in relevant brain biochemical metabolism using magnetic resonance spectroscopy.

Timeline

Start
2015-12-01
Primary completion
2017-04-30
Completion
2017-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Creatine Other / unclassified 5 g
Comparator Cytidine Small molecule 2 g
Comparator Valproate Small molecule 300 mg

Indications